CRBN and neuroendocrine carcinoma: To validate the causal relationship between NEC-driving factors and the transcriptional activity of the CRBN promoter observed in our NGS-based analyses, we performed a CUT&RUN assay targeting H3K27ac, followed by manual qPCR to quantify enrichment (Supplementary Figure S9D).